Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the messenger ribonucleic acid (mrna) synthesis raw materials market grown over the years?
The market size of raw materials for the synthesis of messenger ribonucleic acid (mRNA) has experienced consistent expansion in the past years. It is projected to increase from $2.99 billion in 2024 to $3.06 billion in 2025, with a compound annual growth rate (CAGR) of 2.5%. Factors contributing to growth in the historical period include the progress in biomedical research, escalated interest in vaccines and therapeutics, the demand for personalized medicine, readiness and response to epidemics, and the development of the biotech industry.
What Is the forecasted market size and growth rate for the messenger ribonucleic acid (mrna) synthesis raw materials market?
In the succeeding years, a consistent upward trend is projected for the messenger ribonucleic acid (mRNA) synthesis raw materials market, with its size likely to expand to $3.54 billion in 2029 with a compound annual growth rate (CAGR) of 3.7%. This growth projection is ascribed to factors like supply chain optimization, market growth and commercialization, burgeoning investments in biotech and pharma, regulatory endorsements and support, and extension of therapeutics. The forecast period is anticipated to witness major trends such as the arrival of new market players, quality control and standardization, matters on intellectual property and licensing, global reach and equity, as well as a shift towards more sustainable and scalable manufacturing.
Get your messenger ribonucleic acid (mrna) synthesis raw materials market report here!
What are the major factors driving growth in the messenger ribonucleic acid (mrna) synthesis raw materials market?
The mRNA synthesis raw materials market is projected to grow due to the increasing prevalence of cancer and chronic diseases. Cancer is characterized by the relentless growth and spread of aberrant cells that can invade adjacent tissues and potentially spread to other body parts through the bloodstream and lymph systems. Chronic diseases are generally defined as conditions that last a year or more, require ongoing medical care, and hamper everyday activities or both. mRNA synthesis raw materials find use in pharmaceutical research, vaccine formulation, and the production of RNA-based therapeutics. They present advantages like improved immunogenicity, heightened efficiency, and reduced production time, which makes them suitable for treating cancer and chronic diseases. To put it in perspective, according to the American Cancer Society Facts and Figures, a professional organization based in the US, in 2022, the country recorded about 1.9 million new cancer cases and 609,360 fatalities. The projections for 2023 foresee a minor increase to more than 1.9 million new cases and roughly 609,820 fatalities. Hence, the escalating occurrence of cancer and chronic diseases fuels the synthesis of raw materials for mRNA. Therefore, the rising incidence of cancer and chronic conditions propels the mRNA synthesis of raw materials.
What key areas define the segmentation of the global messenger ribonucleic acid (mrna) synthesis raw materials Market?
The messenger ribonucleic acid (mRNA) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
What are the top market players propelling the growth of the messenger ribonucleic acid (mrna) synthesis raw materials industry?
Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market include Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
What are the key trends shaping the future of the messenger ribonucleic acid (mrna) synthesis raw materials market?
The rise of product innovation serves as a significant trend propelling the mRNA synthesis raw materials market forward. To consolidate their market position, leading companies within this industry are focusing on developing cutting-edge products. Thermo Fisher Scientific, a renowned company based in the U.S., specializing in instrumentation, reagents, consumables, and software services, launched Dynabeads Solutions in September 2022. This bead is designed to help scale up the synthesis and purification process of mRNA for vaccine production to a GMP-grade level. The Dynabeads Streptavidin for In Vitro Transcription has been engineered to simplify the process of solid-phase IVT of cell-free mRNA, and can reuse the DNA template up to six times. This feature minimizes the complexity of the plasmid creation process, while simultaneously enhancing mRNA yields at varying scales, spanning from grams to grams. This innovation will further facilitate the creation of an efficient workflow, helping mRNA companies to transition smoothly from the development stage to commercialization.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12336
What regions are dominating the messenger ribonucleic acid (mrna) synthesis raw materials market growth?
North America was the largest region in the mRNA synthesis raw materials market in 2024. The regions covered in the messenger ribonucleic acid (mRNA) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Non-Animal Alternatives Testing Global Market Report 2024
RNA Analysis/ Transcriptomics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
NGS-Based RNA-Sequencing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
